297 related articles for article (PubMed ID: 12929929)
1. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.
Yamanaka Y; Tanaka H; Koike M; Nishimura R; Seino Y
J Bone Miner Res; 2003 Aug; 18(8):1395-403. PubMed ID: 12929929
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the treatment of achondroplasia.
Yamanaka Y; Ueda K; Seino Y; Tanaka H
Horm Res; 2003; 60 Suppl 3():60-4. PubMed ID: 14671399
[TBL] [Abstract][Full Text] [Related]
4. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1.
Harada D; Yamanaka Y; Ueda K; Nishimura R; Morishima T; Seino Y; Tanaka H
Bone; 2007 Aug; 41(2):273-81. PubMed ID: 17561467
[TBL] [Abstract][Full Text] [Related]
5. PTH has the potential to rescue disturbed bone growth in achondroplasia.
Ueda K; Yamanaka Y; Harada D; Yamagami E; Tanaka H; Seino Y
Bone; 2007 Jul; 41(1):13-8. PubMed ID: 17466614
[TBL] [Abstract][Full Text] [Related]
6. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
Naski MC; Wang Q; Xu J; Ornitz DM
Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
[TBL] [Abstract][Full Text] [Related]
7. A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia.
Chen L; Li C; Qiao W; Xu X; Deng C
Hum Mol Genet; 2001 Mar; 10(5):457-65. PubMed ID: 11181569
[TBL] [Abstract][Full Text] [Related]
8. FGFR3 down-regulates PTH/PTHrP receptor gene expression by mediating JAK/STAT signaling in chondrocytic cell line.
Li M; Seki Y; Freitas PH; Nagata M; Kojima T; Sultana S; Ubaidus S; Maeda T; Shimomura J; Henderson JE; Tamura M; Oda K; Liu Z; Guo Y; Suzuki R; Yamamoto T; Takagi R; Amizuka N
J Electron Microsc (Tokyo); 2010; 59(3):227-36. PubMed ID: 20356821
[TBL] [Abstract][Full Text] [Related]
9. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells.
Henderson JE; Naski MC; Aarts MM; Wang D; Cheng L; Goltzman D; Ornitz DM
J Bone Miner Res; 2000 Jan; 15(1):155-65. PubMed ID: 10646125
[TBL] [Abstract][Full Text] [Related]
10. The biological action of parathyroid hormone-related peptide (PTHrP) and fibroblast growth factor receptor 3 (FGFR3) on bone and cartilage.
Amizuka N; Ozawa H; Sasaki T
Kaibogaku Zasshi; 2000 Oct; 75(5):415-25. PubMed ID: 11155687
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
Adar R; Monsonego-Ornan E; David P; Yayon A
J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
[TBL] [Abstract][Full Text] [Related]
12. Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development.
Amizuka N; Davidson D; Liu H; Valverde-Franco G; Chai S; Maeda T; Ozawa H; Hammond V; Ornitz DM; Goltzman D; Henderson JE
Bone; 2004 Jan; 34(1):13-25. PubMed ID: 14751559
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B
Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.
Cormier S; Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Bonaventure J; Silve C
Am J Pathol; 2002 Oct; 161(4):1325-35. PubMed ID: 12368206
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein (PTHrP) inhibits mitochondrial-dependent apoptosis through CK2.
Okoumassoun LE; Russo C; Denizeau F; Averill-Bates D; Henderson JE
J Cell Physiol; 2007 Sep; 212(3):591-9. PubMed ID: 17443683
[TBL] [Abstract][Full Text] [Related]
16. [Fibroblast growth factor receptor and achondroplasia].
Tanaka H
Clin Calcium; 2006 Nov; 16(11):1888-93. PubMed ID: 17079857
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.
Legeai-Mallet L; Benoist-Lasselin C; Munnich A; Bonaventure J
Bone; 2004 Jan; 34(1):26-36. PubMed ID: 14751560
[TBL] [Abstract][Full Text] [Related]
18. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
19. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.
L'Hôte CG; Knowles MA
Exp Cell Res; 2005 Apr; 304(2):417-31. PubMed ID: 15748888
[TBL] [Abstract][Full Text] [Related]
20. Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia.
Xie Y; Su N; Jin M; Qi H; Yang J; Li C; Du X; Luo F; Chen B; Shen Y; Huang H; Xian CJ; Deng C; Chen L
Hum Mol Genet; 2012 Sep; 21(18):3941-55. PubMed ID: 22634226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]